Houck Philipp, Hache Manon, Busse Jennifer
*College of Physicians and Surgeons†School of Nursing, Columbia University, New York, NY.
J Neurosurg Anesthesiol. 2016 Oct;28(4):389-391. doi: 10.1097/ANA.0000000000000352.
During the second day of the Pediatric Anesthesia NeuroDevelopment Assessment (PANDA) symposium 2016, 3 invited speakers focused on future directions for the PANDA group. This session, entitled "The Way Forward," included 3 talks on how other groups have organized through public-private partnerships (ACTTION), obtained NIH funding, and how to better communicate a research message. Dr Robert H. Dworkin spoke on the mission of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities and Networks (ACTTION), which is a public-private partnership with the United States Food and Drug Administration that pushes forward research related to pain and analgesics. Dr Tracy King discussed National Institute of Health funding for future studies in neurocognitive development after exposure to anesthetics. Dr Sharon Hertz discussed how the PANDA group might better craft their message to the public regarding effects of analgesics on neurocognitive development. Through their talks, the above speakers provided a clear route for the way forward in regard to research, funding, and messaging for the PANDA group.
在2016年儿科麻醉神经发育评估（PANDA）研讨会的第二天，三位受邀演讲者聚焦于PANDA团队的未来发展方向。本次会议题为“前进之路”，包括三场关于其他团队如何通过公私合作（ACTTION）进行组织、获得美国国立卫生研究院（NIH）资助以及如何更好地传达研究信息的演讲。罗伯特·H·德沃金博士讲述了镇痛、麻醉与成瘾临床试验转化、创新、机遇及网络（ACTTION）的使命，ACTTION是与美国食品药品监督管理局的公私合作项目，推动与疼痛和镇痛药相关的研究。特蕾西·金博士讨论了美国国立卫生研究院为麻醉暴露后神经认知发育的未来研究提供资金的情况。莎伦·赫兹博士探讨了PANDA团队如何更好地向公众传达镇痛药对神经认知发育影响的信息。通过他们的演讲，上述演讲者为PANDA团队在研究、资金和信息传达方面的前进之路提供了清晰的方向。
